The June Inflation report doesn't reverse a 63-month (and counting) trend of above-target price increases.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
FuelCell Energy (FCEL) has been active on the regulatory front, filing several out of time motions to intervene at the Federal Energy Regulatory Commission that address how large electric loads connect to transmission grids across multiple US power markets. See our latest analysis for FuelCell Energy. These Federal Energy Regulatory Commission interventions come after FuelCell Energy signed a memorandum of understanding with Siemens AG to support 100+ MW distributed fuel cell projects. They...
Generic drugmakers have much thinner margins, and are less interested in “reshoring” to the US where the costs are higher.
Bank of America CEO Brian Moynihan turned heads during a NewsNation debate, warning that sticky inflation may leave the Federal Reserve with no choice but to raise interest rates again later this year. Moynihan argued that pipeline costs, energy pressures, and persistent household expenses ...
Earlier in July, a federal judge blocked Colorado’s plan to impose a 70% price cap on Amgen’s blockbuster arthritis drug Enbrel, halting a significant state-level pricing move. The ruling eased concerns that aggressive state pricing limits on Enbrel could spread more widely, reducing a key regulatory overhang for Amgen’s portfolio. We’ll now explore how this legal setback to Colorado’s price cap effort could influence Amgen’s investment narrative and perceived long-term risks. Find 47...
On July 22, 2026, traders digested a weaker yen and increasing oil prices as major cryptos softened, though institutional inflows kept Bitcoin supported.
The company said sales were boosted by strong demand from the U.S. federal government, which accelerated some on-premise subscription revenues.
Wabtec was the No. 2 S&P 500 stock on Wednesday after the supplier of locomotives and railcars for freight and passenger service topped Q2 earnings estimates and raised its full-year outlook. Strong international performance, backlog growth and a wider profit margin — despite tariffs — powered Wabtec shares toward the top of a buy zone. Results: Wabtec posted adjusted earnings per share of $2.76, up 21.6% from a year ago and 16 cents ahead of estimates.
Paramount's bid still faces hurdles across the Atlantic after a federal judge in California ordered the companies to temporarily pause their merger this week.View on euronews
Infleqtion received three Department of Energy research projects and led gains among the companies tied to the initiative.
JPMorgan Chase just had the most profitable quarter in its history. Second-quarter net income came in at $21.2 billion, powered by a surge in trading revenue and a gain on its Visa stake. The S&P 500 is up close to 10% this year. Consumers are still spending. Inflation has moderated. By most ...
Bond yields continued to climb on Thursday as oil prices rose amid an escalating conflict in the Middle East.
Bond yields continued to climb on Wednesday as oil prices rose amid an escalating conflict in the Middle East.
ISRG's growth is fueled by robotic surgery, Ion lung biopsy and AI tools, while tariffs, product mix and softer demand pressure margins.
ISRG's strong procedure growth, recurring revenue and cash position support its case, but tariffs, mix shifts and placement risks cloud the outlook.
The European stock markets closed higher in Wednesday trading as strong earnings reports outweighed
July 22 (Reuters) - A federal judge has ruled that New York City cannot prohibit Uber Technologies and Lyft from deactivating drivers from their apps without advance notice, ruling that the novel law is unconstitutional. District Judge Gregory Woods in Manhattan said in a written ruling on Tuesday that the city's law adopted earlier this year benefits a small fraction of drivers while interfering with the ride-hailing companies' right to police the safety of their platforms.
Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter can be downloaded here. Despite volatile oil prices and rising inflation, U.S. equities reached record highs in Q2 2026, driven by a technology-led rally, particularly in memory semiconductors. The Fund’s […]
Oklo has shed more than 70% from its peak while simultaneously landing federal AI-nuclear contracts and a massive hyperscaler pipeline that rivals see as the future of data center power. Whether that gap is a warning sign or a generational entry point comes down to one critical timeline.
Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter can be downloaded here. Despite volatile oil prices and rising inflation, U.S. equities reached record highs in Q2 2026, driven by a technology-led rally, particularly in memory semiconductors. The Fund’s […]
Dodge & Cox Fund, an investment management company, released its second-quarter 2026 investor letter for “Dodge and Cox Stock Fund”. A copy of the letter can be downloaded here. Despite volatile oil prices and rising inflation, U.S. equities reached record highs in Q2 2026, driven by a technology-led rally, particularly in memory semiconductors. The Fund’s […]
Treasury yields continue to tick higher alongside oil prices, putting the 10-year yield close to its 2026 high point. The yield on the 10-year note climbed to 4.648% in morning trading, according to Tradeweb, just shy of the 4.687% intraday high that it reached on May 19. The uptick in oil prices is making investors more worried about the inflation outlook, with traders now seeing a roughly 50% chance that the Federal Reserve raises interest rates twice before the end of the year.
(Bloomberg) -- President Donald Trump’s threat of 100% tariffs against generic medicines is a major expansion of a strategy he’s been using against the pharmaceutical industry since his second term began. Most Read from BloombergTrump’s 100% Generic Drug Duty Threatens US Low-Cost SupplyApple to Launch ‘Upgrade’ Device Leasing Program With Klarna to Spur SalesTrump Extends Pardons to Companies, Echoing a 17th Century KingSpaceX Set to Unlock $116 Billion in Shares After IPO Restrictions LiftKrem
The Energy Department program targets faster licensing and construction for AI data center power
Bank of America is breaking with the Fed's wait-and-see approach and pushing for rate hikes now, which reshuffles the entire investing playbook. Four dividend-paying stocks across the sectors that quietly thrive when borrowing costs climb deserve a closer look.
Brent crude briefly topped $95 a barrel Wednesday after an 11th consecutive night of U.S. strikes against Iran, with Fed rate hike odds climbing
The automaker also cited cost pressures tied to inflation and the manufacturing expenses related to onshoring more production to the U.S. for the decline in Q2 profit.
Because federal over-regulation has frightened off private investors a new pipeline will only get built if taxpayers finance it
Stocks were on track to open lower on Wednesday after a jump in oil prices revived fears that a flare-up in inflation could drag down the market. Nasdaq 100 futures fell 0.8%. Stocks looked set to give up some of those gains on Wednesday amid a rally in oil prices, after the U.S. launching strikes against Iran for an 11th straight night.